Management

Tahir Mahmood, PhD

Chief Executive Officer & Co-founder

Tahir co-founded AMT, where he has overseen the company’s growth from concept to clinical trials in patients through multiple equity financing rounds. He was closely involved in the early development of the technology and also led the company’s partnering and corporate development activities. | READ MORE

Randall Mrsny, PhD

Chief Science Officer & Co-founder

An epithelial biologist, Randy has more than three decades of industry and academic experience in pharmaceutical sciences and research into the mucosal trafficking of peptide and protein therapeutics.  | READ MORE

Bittoo Kanwar, MD

Senior Vice President, Head of Clinical Development

Bittoo leads Clinical Development activities at Applied Molecular Transport, where he is overseeing the current clinical program AMT-101 and developing clinical strategy for the company’s pipeline assets and technology platforms. | READ MORE

Brandon Hants

Vice President, Finance and Business Operations

Brandon has twenty years of biotechnology experience in various disciplines from both large and small companies. He has held roles in Financial Planning & Analysis, Accounting, Financial Systems, Treasury, Operations Finance, Supply Chain and Manufacturing. | READ MORE

Derek Maclean, PhD

Vice-President, Pharmaceutical Sciences

Derek is a pharmaceutical scientist with over 20 years of operational and management experience in medicinal chemistry, formulation development, and product manufacturing. Prior to joining Applied Molecular Transport, Derek was Vice-President of Chemistry Research at Relypsa Inc, leading the chemical development of advanced polymer therapeutics. | READ MORE

Chuck Olson

Vice President, Head of Biologics

Chuck is a biotechnology industry professional with broad scientific and operational experience, having a focus in process development, manufacturing and other CMC related activities.  With over thirty years of experience, he has enabled the production of virtually every class and size of biological product from recombinant proteins, enzymes, blood products, natural products, adenovirus and whole cell immunotherapy. | READ MORE